Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis

There is growing evidence that central blood pressure is a better predictor of hypertensive end-organ damage and cardiovascular outcome than routine brachial readings.

The investigators aimed to evaluate the accuracy of a novel device for the non-invasive determination of central blood pressure based on automated oscillometric radial pulse wave analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arterial Hypertension Cardiovascular Diseases Coronary Disease Coronary Heart Disease Heart Diseases Hypertension Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients undergoing routine coronary angiography

Exclusion criteria

inability to give informed consent
hemodynamic instability

Treatment and study plan

Primary outcomes

agreement of systolic central blood pressure measurements

Time frame: 15 minutes
agreement of diastolic central blood pressure measurements

Time frame: 15 minutes

Sponsors and collaborators

Lead sponsor

Universitätsmedizin Mannheim

Other

Registry information

Official study title

Non-invasive Automated Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis - Comparison With Invasive Reference Values

Acronym: MEASURE-cBP1

Important dates

Study start: 2013
Primary completion: 2017
Study completion: 2017
First posted: Feb 8, 2017
Registry last updated: Dec 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed